The experimental antiviral drug Molnupiravir is expected to become available in Slovenia from tomorrow to treat vulnerable patients with COVID-19.
The experimental antiviral drug Molnupiravir is expected to become available in Slovenia from tomorrow for the treatment of COVID-19, especially for vulnerable patients who have higher risk factors or underlying health issues.
The drug was originally developed to treat a different virus but showed strong results in fighting other viruses, such as influenza and Ebola.
It's name was inspired by the name of Thor's hammer, Mjolnir.
Voluntary vaccination of children aged between 5 and 11 is also expected to begin next week.
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.